Inventor
O'CONNOR STEPHEN J
US25 patents
⚠️ This page may combine multiple inventors who share the name “O'CONNOR STEPHEN J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BAYER PHARMACEUTICALS CORP
5 patentsUS6660752B2Dec 9, 2003
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
BAYER PHARMACEUTICALS CORP24 citations92
US6960601B2Nov 1, 2005
Preparation and use of imidazole derivatives for treatment of obesity
BAYER PHARMACEUTICALS CORP26 citations91
US6699860B2Mar 2, 2004
Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonists
BAYER PHARMACEUTICALS CORP8 citations71
US6919371B2Jul 19, 2005
2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
BAYER PHARMACEUTICALS CORP2 citations62
US7071207B2Jul 4, 2006
Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity
BAYER PHARMACEUTICALS CORP0 citations40
UNIV PITTSBURGH
4 patentsUS6221865B1Apr 24, 2001
Inhibitors of protein isoprenyl transferases
UNIV PITTSBURGH30 citations92
US6204293B1Mar 20, 2001
Inhibitors of protein isoprenyl transferases
UNIV PITTSBURGH26 citations92
US6310095B1Oct 30, 2001
Inhibitors of protein isoprenyl transferases
UNIV PITTSBURGH39 citations91
US6693123B2Feb 17, 2004
Inhibitors of protein isoprenyl transferases
UNIV PITTSBURGH7 citations73
ABBOTT LAB
4 patentsUS5631401AMay 20, 1997
Inhibitors of protein farnesyltransferase and squalene synthase
ABBOTT LAB35 citations91
US5783593AJul 21, 1998
Inhibitors of squalene synthetase and protein farnesyltransferase
ABBOTT LAB19 citations82
US5831115ANov 3, 1998
Inhibitors of squalene synthase and protein farnesyltransferase
ABBOTT LAB8 citations73
US6277871B1Aug 21, 2001
Inhibitors of protein isoprenyl transferases
ABBOTT LAB6 citations60
CARA THERAPEUTICS INC
4 patentsUS11033629B2Jun 15, 2021
Oral formulations of kappa opioid receptor agonists
CARA THERAPEUTICS INC4 citations73
US11986509B2May 21, 2024
Oligosaccharide formulations of kappa opioid receptor agonists
CARA THERAPEUTICS INC0 citations62
US11684674B2Jun 27, 2023
Oral formulations of kappa opioid receptor agonists
CARA THERAPEUTICS INC1 citations62
US7960377B2Jun 14, 2011
Substituted pyridoxazines
CARA THERAPEUTICS INC0 citations39